COVID-19疫情对癌症的影响 多学科团队会议. 一个多中心的法国体验
Wafa Bouleftour1, Amandine Mondiere-Wichurski2, Pierre Fournel1,2
1Department of Medical Oncology, North Hospital, University Hospital of Saint-Etienne, Saint-Etienne, France.
Cancer investigation
|February 6, 2024
概括
由于COVID-19大流行,癌症护理的多学科团队会议 (MDTs) 受到干扰,减少了案例讨论. 到第四波,MDT活动恢复正常,突出显示了对虚拟解决方案的需求.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健管理的管理
背景情况:
- 多学科团队会议 (MDT) 是标准癌症护理的组成部分.
- 在全球范围内,COVID-19大流行给医疗保健系统带来了巨大的压力.
- 通过MDT对癌症护理协调的影响需要紧急分析.
研究的目的:
- 分析COVID-19流行病对法国区域卫生系统中MDT的影响.
- 评估疫情期间癌症病例讨论量和频率的变化.
- 在未来的健康危机中确定MDT组织的潜在改进.
主要方法:
- 来自法国一个区域卫生机构的MDT记录的回顾性分析.
- 在COVID-19流行病最初波浪之前,期间和之后的MDT活动的比较.
- 包括来自各种癌症子专业 (血液学,消化,胸部,妇科,泌尿生殖) 的数据.
主要成果:
- 在第一个COVID-19波之后,在多个MDT中讨论的病例数量显著下降.
- 这种MDT活动的减少持续到第二波和第三波的流行病.
- 从第四波开始,MDT的运营逐渐恢复到大流行前的水平.
结论:
- 随着COVID-19的流行,癌症MDT的既定功能受到极大的挑战.
- 疫情强调了传统的MDT结构对重大健康危机的脆弱性.
- 实施虚拟技术为提高MDT的弹性和组织提供了一个有希望的途径.
更多相关视频
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023
7.6K
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10.6K
相关概念视频
01:21Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K